Study to Evaluate the Safety and Efficacy of the 10 GE Xenokidney in Patients With ESRD

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

August 31, 2025

Primary Completion Date

August 31, 2075

Study Completion Date

August 31, 2075

Conditions
ESRD (End-Stage Renal Disease)Kidney TransplantationXenotransplantation
Interventions
BIOLOGICAL

10 GE Xenokidney

Porcine-derived kidney containing intentional genomic alterations for xenotransplantation

Trial Locations (1)

10016

RECRUITING

New York University Langone Health, New York

Sponsors
All Listed Sponsors
lead

United Therapeutics

INDUSTRY